Abstract MO44 – Table 1. Prevalence of SARS‐CoV‐2 PCR tests, results, and hospitalisations in the EuroSIDA regions in 2020.
SARS‐CoV‐2 PCR testing and results	Total (N = 7228)	Southern Europe (N = 1723)	Central Western Europe (N = 1071)	Northern Europe (N = 1588)	Central Eastern Europe (N = 1584)	Eastern Europe (N = 940)	Argentina (N = 322)
Tested, N	1070	236	122	513	88	67	44
Tested, % (95% CI)	14.8 (14.0 to 15.6)	13.7 (12.1 to 15.4)	11.4 (9.6 to 13.5)	32.3 (30.0 to 34.7)	5.6 (4.5 to 6.8)	7.1 (5.6 to 9.0)	13.7 (10.1 to 17.9)
Positive, N	140	39	23	15	33	12	18
Positive, % (95% CI)	1.9 (1.6 to 2.3)	2.3 (1.6 to 3.1)	2.1 (1.4 to 3.2)	0.9 (0.5 to 1.6)	2.1 (1.4 to 2.9)	1.3 (0.7 to 2.2)	5.6 (3.4 to 8.7)
Negative, N	930	197	99	498	55	55	26
Negative, % (95% CI)	12.9 (12.1 to 13.7)	11.4 (10.0 to 13.0)	9.2 (7.6 to 11.1)	31.4 (29.1 to 33.7)	3.5 (2.6 to 4.5)	5.9 (4.4 to 7.6)	8.1 (5.3 to 11.6)
Hospitalised due to SARS‐CoV‐2, N	28	8	5	4	5	5	1
Hospitalised due to SARS‐CoV‐2, % (95% CI)	0.4 (0.3 to 0.6)	0.5 (0.2 to 0.9)	0.5 (0.2 to 1.1)	0.3 (0.1 to 0.6)	0.3 (0.1 to 0.7)	0.5 (0.2 to 1.2)	0.3 (0.0 to 1.7)